Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Within the broader context of the pharmaceutical i
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
For the first time in its chronicle, the pharmaceu
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
Neutralizing antibodies (nAbs) against SARS-CoV-2 represent a promising option for treating COVID-19. Screening a large and diverse antibody phage library has allowed for the rapid discovery of anti-SARS-CoV-2 nAbs.
In this expert webinar, find out how high-throughput epitope binning and mapping using using label-free biolayer interferometry (BLI) detection and advanced flow cytometry systems has enabled the development of an antibody cocktail that can reduce the risk of drug resistance.
For more information and recording : Click here